Jaguar Health, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Partners With MedinCell On Up To

“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Vanda Pharmaceuticals Inc. 's agreement to license a portfolio of preclinical cystic fibrosis transmembrane conductance regulator (CFTR) modulators from the University of California, San Francisco